We have previously reported' activation of infectious SV40 in transformed cell types of various origins after fusion with susceptible African green monkey kidney cells (AGMK). In the same report, we described failure to activate SV40 after fusion of AGMK cells with two sublines of SV40-transformed human cells (W98-VaC and WI26Va4) and cultures originating from four clones of SV40-transformed green monkey kidney cells (GMK-EVa).
We have previously reported' activation of infectious SV40 in transformed cell types of various origins after fusion with susceptible African green monkey kidney cells (AGMK). In the same report, we described failure to activate SV40 after fusion of AGMK cells with two sublines of SV40-transformed human cells (W98-VaC and WI26Va4) and cultures originating from four clones of SV40-transformed green monkey kidney cells (GMK-EVa).
The present report describes activation of SV40 after fusion of some of these cells with other transformed cells. Materials and Methods.-Tissue cultures: These were described previously,' and their characteristics are summarized in Table 1 . Except for F5-1, all cell lines were transformed by SV40 in tissue cultures.' F5-1 is a cell line originally derived from a hamster fibrosarcoma induced by SV402 and maintained in tissue culture for 89 passages. The SV40 pool used for induction of the F5-1 tumor was different from the pool used for transformation of tissue cultures.
For assay of infectious SV40, we used primary AGMK cultures; for fusion purposes, we used secondary cultures of AGMK cells.
Cell fusion technique: The technique was the same as that described previously,' except that Sendai virus was inactivated by 0.025% 3-propiolactone instead of ultraviolet light (UV), and the medium used at the time of fusion contained 2%, instead of 10%, fetal calf serum.
When three instead of two types of cells were to be fused, suspensions of the two transformed cells were exposed to Sendai virus for 5 min at +4"C, and an equal number (5.0 X 106) of AGMK cells was then added to the cell mixture. After further incubation at +40C for 5 min, the cell mixture was treated exactly as described before. ' Isolation of infectious SV40: One, two, and three weeks after fusion, the bulk of the medium was removed, and the cells in 6-10 ml of medium (per milk dilution bottle) were frozen and thawed three times before inoculation on AGMK monolayers. Alternatively, the fused cells were scraped off the glass and sonicated in 6 ml of medium; the extract was then inoculated on monolayers of AGMK.
The inoculated AGMK cultures were incubated at 370C and observed for the presence of cytopathic effect. In order to confirm the presence of infectious SV40, cells of cultures showing cytopathic effect were scraped off the glass by freezing and thawing, and the cell extract was placed on coverslip cultures of AGMK cells. These were stained by immunofluorescence to determine the presence of SV4O-induced complement fixation (T) and viral coat (VP) antigens.3
Results.-These are summarized in Table 2 respectively, without additional fusion with AGMK cells. This can be explained by the fact that cells of clone 2A-1 culture, although resistant to superinfection with complete virus, are capable of synthesizing infectious SV40 after exposure to viral DNA.4 Three other fusions (see Table 2 ) of cells of two transformed lines with AGMK cells resulted in the isolation of SV40; however, virus was not isolated when the transformed cells were fused in the absence of AGMK.
Cell extracts of heterokaryon cultures usually became infectious one to three weeks after fusion.
In the AGMK assay system, cytopathic effect was first observed within one week after inoculation with undiluted extract of fused cells. The concentration of "rescued" SV40 obtained by fusion of cells from the transformed lines in the absence of AGMK (clone 2A-1 with F5-1 and with W98VaC, respectively) was low, since a 1:10 dilution of the original extract was already not infectious.
Discussion.-In mouse cells transformed by SV40, the virus isolated after cocultivation or fusion with SV40-susceptible cells will bear the genetic marker characteristic of the original "inducing" virus.' Since we have no knowledge of the genetic characteristics of the SV40 used for transformation of the cell lines described in this paper, it is impossible to determine whether we are dealing in this study with activation by recombination or complementation of two types of defective virus particles juxtaposed in the same heterokaryocyte or in a synkaryon. Virus particles bearing characteristics of defective mutants were shown to be present in SV40 pools by Sauer et al.6 In addition, others7 8 have shown an increase in the population of defective particles in SV40 populations when the virus was passaged in susceptible cells at high multiplicities of infection.
In Table 3 Activation of SV40 depends on the condition of the viral genome in the transformed cell as well as on the presence or absence of factors in the host cell affecting the status of the viral genome. In cells from which the virus could be recovered after cocultivation or fusion with susceptible cells, the viral genome has to be complete, but expression of its late function is repressed. The nature of the "repressor" is currently under study.
Conversely, cells that yield SV40 only after fusion with other transformed cells may contain SV40 genomes defective at different loci in the two types of cells.
In this case, recombination of or complementation between the defective particles in a heterokaryocyte would explain the appearance of complete virus. It is im-possible to state at this time whether a host factor also plays a role in this "rescue" process.
Summary.-Cells of some SV40-transformed cultures do not yield virus after fusion with susceptible AGMK cells in the presence of Sendai virus. When cells from SV40-transformed cultures are fused with cells of another of these cultures, SV40 is rescued either by recombination or by complementation.
